Foresight Group Ltd Liability Partnership lowered its holdings in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 96.7% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,693 shares of the real estate investment trust's stock after selling 553,640 shares during the period. Foresight Group Ltd Liability Partnership's holdings in Healthcare Realty Trust were worth $313,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in HR. Starboard Value LP purchased a new position in Healthcare Realty Trust in the fourth quarter valued at $342,110,000. Massachusetts Financial Services Co. MA acquired a new stake in Healthcare Realty Trust in the 1st quarter valued at about $100,817,000. Rush Island Management LP raised its position in Healthcare Realty Trust by 21.2% in the 4th quarter. Rush Island Management LP now owns 15,681,440 shares of the real estate investment trust's stock valued at $265,800,000 after purchasing an additional 2,747,848 shares in the last quarter. Centersquare Investment Management LLC purchased a new position in shares of Healthcare Realty Trust in the 1st quarter valued at about $30,834,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Healthcare Realty Trust during the first quarter worth about $22,285,000.
Healthcare Realty Trust Stock Down 1.7%
Shares of Healthcare Realty Trust stock opened at $18.37 on Thursday. Healthcare Realty Trust Incorporated has a 52 week low of $14.09 and a 52 week high of $18.90. The firm's 50 day moving average is $16.64 and its two-hundred day moving average is $15.98. The firm has a market capitalization of $6.46 billion, a P/E ratio of -15.97 and a beta of 0.94.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.01. The business had revenue of $287.07 million during the quarter, compared to analysts' expectations of $290.83 million. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. During the same quarter in the prior year, the business posted $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. As a group, research analysts expect that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current fiscal year.
Healthcare Realty Trust Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend was Thursday, August 14th. Healthcare Realty Trust's payout ratio is presently -83.48%.
Analyst Ratings Changes
HR has been the topic of a number of recent research reports. JPMorgan Chase & Co. cut their target price on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday, June 26th. Wells Fargo & Company increased their price objective on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the company an "underweight" rating in a research report on Wednesday, August 27th. BTIG Research restated a "buy" rating and issued a $20.00 price objective on shares of Healthcare Realty Trust in a report on Wednesday. Wall Street Zen cut shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Finally, Scotiabank upgraded shares of Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and boosted their target price for the stock from $18.00 to $20.00 in a research note on Friday, September 5th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Healthcare Realty Trust presently has an average rating of "Hold" and a consensus target price of $17.67.
Check Out Our Latest Stock Analysis on Healthcare Realty Trust
Insider Activity at Healthcare Realty Trust
In other news, EVP Julie F. Wilson sold 15,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $18.00, for a total value of $270,000.00. Following the completion of the sale, the executive vice president directly owned 113,419 shares of the company's stock, valued at approximately $2,041,542. This represents a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas N. Bohjalian purchased 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The shares were acquired at an average price of $16.46 per share, with a total value of $164,600.00. Following the purchase, the director owned 75,520 shares in the company, valued at $1,243,059.20. This trade represents a 15.26% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.37% of the stock is currently owned by corporate insiders.
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories
Want to see what other hedge funds are holding HR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Realty Trust Incorporated (NYSE:HR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.